Middle East & Africa Fill Finish Manufacturing Market Forecast to 2030

Middle East & Africa Fill Finish Manufacturing Market Forecast to 2030 – Regional Analysis – by Product (Consumables {Prefilled Syringes, Glass Vial/Plastic Vials, Cartridges, and Others} and Instruments), Modality (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others), and End User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Others)

Send Enquiry
Item ID: BMIRE00030449  Category: Tag:

$2,485$3,885

Description

The Middle East & Africa fill finish manufacturing market was valued at US$ 522.33 million in 2022 and is expected to reach US$ 953.58 million by 2030; it is estimated to record a CAGR of 7.8% from 2022 to 2030.

Single-Use Systems for Aseptic Fill Finish Bolster Middle East & Africa Fill Finish Manufacturing Market

Single-use disposable systems (SUDS) and single-use systems (SUS) for aseptic fill finish save time for pharmaceutical manufacturers, thereby allowing them to streamline their operations and shorten project schedules. Incorporating SUDS also helps them ensure regulatory compliance as well as confer environmental, health, and safety (EHS) benefits and facility design advantages. Furthermore, SUS accelerates the change over fill finish operations by simplifying end-of-batch breakdown and decontamination operations; the simplification of decontamination operations involves the elimination of time-consuming cleaning and preparation steps. The SUS is now being used in fill-finish operations.

Bulk biotech operations have successfully deployed single-use systems for buffer and media preparations. They are currently implementing new single-use technologies such as fermentation and chromatography systems. Recent advancements in technology are making SUDS increasingly attractive for aseptic operations. For instance, a single-use line is a perfect fit for parenteral solution products with relatively low batch sizes (50-500L) that a peristaltic pump can transfer. Thus, rise in use of single use system for aseptic fill finish manufacturing will provide future trends in near future.

Middle East & Africa Fill Finish Manufacturing Market Overview

South Africa is one of the fastest-growing countries in the Middle East & Africa, and the market growth is driven by a rise in research & development activities, including pharmaceutical and biotechnology-related activities, and growing number of healthcare facilities. The rise in awareness of health issues and increasing consumption of medication are other factors driving the market. The government of South Africa is promoting and offering several incentives for domestic manufacturing of drugs, which, in turn, can fuel the overall market growth in this country in the coming years. Also, the country’s healthcare system is developing at a rapid pace, as an increasing number of sponsors are developing medical and research teams in the country. A sharp increase in the state health budget is also expected to increase the demand for fill-finish manufacturing in the country.

Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Fill Finish Manufacturing Market Segmentation

The Middle East & Africa fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Middle East & Africa fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the Middle East & Africa fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.

By end user, the Middle East & Africa fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.

Based on country, the Middle East & Africa fill finish manufacturing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa fill finish manufacturing market share in 2022.

Becton Dickinson and Co, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Middle East & Africa NV, Schott AG, SGD SA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Middle East & Africa fill finish manufacturing market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 7.8% CAGR, Middle East & Africa Fill Finish Manufacturing Market is Speculated to be Worth US$ 953.58 Million by 2030, says the Research Team

According to the Research Team’ research, the Middle East & Africa fill finish manufacturing market was valued at US$ 522.33 million in 2022 and is expected to reach US$ 953.58 million by 2030, registering a CAGR of 7.8% from 2022 to 2030. Growing adoption of prefilled syringes for parenteral administration and significant government initiatives is the critical factors attributed to the Middle East & Africa fill finish manufacturing market expansion.

Parenteral administration is one of the most prominent routes chosen to stimulate immediate immune response and ensure the complete bioavailability of pharmaceutical products. A steady rise in the development and market availability of parenteral drugs has propelled the demand for advanced, cost-effective drug delivery devices that promise ease of administration. The benefits of prefilled syringes over traditional delivery systems include easy administration, improved safety, accurate dosing, and reduced contamination risks. Among drug delivery devices, prefilled syringes represent one of the fastest-growing primary packaging formats, which are designed for dose administration. In the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in approximately three-fold increase in the consumption of prefilled syringes. The sustained preference for the prefilled syringes is attributed to the safety and ease of use of these products. Recent variants are designed with provisions to reduce errors in dosing, risk of occlusions, leakage of fluids (i.e., extravasation), and inflammation of veins (phlebitis). Owing to the benefits mentioned above, several injectable drugs-Humira, Enbrel, Avastin, PREVNAR 13, ALPROLIX, and Benefix, among others-diluents and other products requiring parenteral administration are packaged in prefilled syringes.

The loading of sterile drugs into prefilled syringes is considered one of the most crucial steps in the pharmaceutical production process. Proper fill-finish operations are necessarily carried out under aseptic conditions to maintain pharmacological efficacy and quality and to ensure the safety of end users. The prefilled syringe filling is a complex operation as it requires extremely close monitoring of both the syringe fill volume and the headspace between the liquid filled in the syringe and the bottom of the plunger. In addition, the rise in complexity of small molecule APIs and the increasing diversity of biological drugs contribute to the demand for advanced aseptic fill finish operations.

Companies, including small enterprises and large businesses, outsource their respective fill finish operations to contract service providers. Per the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, manufacturers of biological have been observed to outsource more than 30% of their fill finish operations. With the rise in the demand for prefilled syringes and the growing complexity of fill finish processes, outsourcing these operations is likely to increase in the future. Over 100 companies across the globe are providing fill finish services for prefilled syringe manufacturers. To cater to the growing demand of pharmaceutical products, service providers are actively investing in expanding their existing infrastructure and capabilities; they have also expanded their clientele through service agreements over the past few years. As injectables account for ~55% of drug candidates in the global R&D pipeline, the businesses of prefilled syringe manufacturers and associated service providers are also growing. Due to the emergence of the COVID-19 crisis, vaccine development initiatives have increased across the globe, which significantly boosted the demand for prefilled syringes. Thus, the rising adoption of prefilled syringes for parenteral administration drives the fill finish manufacturing market.

On the contrary, growing competition in biopharmaceutical contract manufacturing industry hurdles the growth of Middle East & Africa fill finish manufacturing market.

Based on product, the Middle East & Africa fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held 56.6% share of Middle East & Africa fill finish manufacturing market in 2022, amassing US$ 295.81 million. It is projected to garner US$ 554.14 million by 2030 to expand at 8.2% CAGR during 2022-2030. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the Middle East & Africa fill finish manufacturing market is categorized into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held 32.2% share of Middle East & Africa fill finish manufacturing market in 2022, amassing US$ 167.97 million. It is projected to garner US$ 317.55 million by 2030 to expand at 8.3% CAGR during 2022-2030.

By end user, the Middle East & Africa fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held 50.6% share of Middle East & Africa fill finish manufacturing market in 2022, amassing US$ 263.62 million. It is projected to garner US$ 489.63 million by 2030 to expand at 8.0% CAGR during 2022-2030.

Based on country, the Middle East & Africa fill finish manufacturing market has been categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 34.6% share of Middle East & Africa fill finish manufacturing market in 2022. It was assessed at US$ 180.52 million in 2022 and is likely to hit US$ 341.09 million by 2030, exhibiting a CAGR of 8.3% during 2022-2030.

Key players operating in the Middle East & Africa fill finish manufacturing market are Becton Dickinson and Co, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Middle East & Africa NV, Schott AG, SGD SA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc, among others.

In September 2022, BD announced the launch of BD Effivax Glass Prefillable Syringe. In collaboration with leading pharmaceutical companies, the prefillable syringe was designed to meet the complex and evolving needs of vaccine manufacturing. The launch of prefillable syringe strategically would support growth and would create needed efficiencies in end-to-end production.

In October 2023, Dara Pharma will be present at CPhI, sharing the Booth 2C29 with its partner ARaymond, and will exhibit a filling and closing machine for vials in nest and RayDyLyo caps, model NFL/2-RDL.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa fill finish manufacturing market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa fill finish manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa fill finish manufacturing market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Fill Finish Manufacturing Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Middle East & Africa Fill Finish Manufacturing Market – Key Industry Dynamics
5.1 Fill Finish Manufacturing Market – Key Industry Dynamics
5.2 Key Market Drivers
5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
5.2.2 Elevating Demand for Biologics
5.3 Key Market Restraints
5.3.1 Complexity in Biologics Manufacturing
5.4 Key Market Opportunities
5.4.1 Significant Government Initiatives
5.5 Key Future Trends
5.5.1 Single-Use Systems for Aseptic Fill Finish
5.6 Impact of Drivers and Restraints:
6. Fill Finish Manufacturing Market – Middle East & Africa Market Analysis
7. Middle East & Africa Fill Finish Manufacturing Market Analysis – Product
7.1 Consumables
7.1.1 Overview
7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Fill Finish Manufacturing Market Analysis – Modality
8.1 Recombinant Proteins
8.1.1 Overview
8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Monoclonal Antibodies
8.2.1 Overview
8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Vaccines
8.3.1 Overview
8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Cell Therapies and Biological Therapies
8.4.1 Overview
8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Gene Therapies
8.5.1 Overview
8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Fill Finish Manufacturing Market Analysis – End User
9.1 Contract Manufacturing Organizations
9.1.1 Overview
9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Fill Finish Manufacturing Market – Country Analysis
10.1 Middle East & Africa
10.1.1 Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts and Analysis – By Country
10.1.1.1 South Africa
10.1.1.2 South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.2.1 South Africa Fill Finish Manufacturing Market Breakdown by Product
10.1.1.2.1.1 South Africa Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.2.2 South Africa Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.2.3 South Africa Fill Finish Manufacturing Market Breakdown by End User
10.1.1.3 Saudi Arabia
10.1.1.4 Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.4.1 Saudi Arabia Fill Finish Manufacturing Market Breakdown by Product
10.1.1.4.1.1 Saudi Arabia Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.4.2 Saudi Arabia Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.4.3 Saudi Arabia Fill Finish Manufacturing Market Breakdown by End User
10.1.1.5 United Arab Emirates
10.1.1.6 United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.6.1 United Arab Emirates Fill Finish Manufacturing Market Breakdown by Product
10.1.1.6.1.1 United Arab Emirates Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.6.2 United Arab Emirates Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.6.3 United Arab Emirates Fill Finish Manufacturing Market Breakdown by End User
10.1.1.7 Rest of Middle East & Africa
10.1.1.8 Rest of Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.8.1 Rest of Middle East & Africa Fill Finish Manufacturing Market Breakdown by Product
10.1.1.8.1.1 Rest of Middle East & Africa Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.8.2 Rest of Middle East & Africa Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.8.3 Rest of Middle East & Africa Fill Finish Manufacturing Market Breakdown by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 IMA Industria Macchine Automatiche SpA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Nipro Medical Europe NV
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Maquinaria Industrial Dara SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 SGD SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Syntegon Technology GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 West Pharmaceutical Services Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Schott AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Becton Dickinson and Co
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Fill Finish Manufacturing Market Segmentation
Table 2. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) – Product
Table 3. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) – Consumables
Table 4. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) – Modality
Table 5. Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Million) – End User
Table 6. South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Product
Table 7. South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Consumables
Table 8. South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Modality
Table 9. South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 10. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Product
Table 11. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Consumables
Table 12. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Modality
Table 13. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 14. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Product
Table 15. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Consumables
Table 16. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Modality
Table 17. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 18. Rest of Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Product
Table 19. Rest of Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Consumables
Table 20. Rest of Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By Modality
Table 21. Rest of Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 22. Recent Inorganic Growth Strategies in the Fill Finish Manufacturing Market
Table 23. Recent Organic Growth Strategies in The Fill Finish Manufacturing Market
Table 24. Glossary of Terms, Fill Finish Manufacturing Market

LIST OF FIGURES

Figure 1. Fill Finish Manufacturing Market Segmentation, By Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Fill Finish Manufacturing Market Revenue (US$ Million), 2022 – 2030
Figure 5. Fill Finish Manufacturing Market Share (%) – Product, 2022 and 2030
Figure 6. Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Fill Finish Manufacturing Market Share (%) – Modality, 2022 and 2030
Figure 9. Recombinant Proteins Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Monoclonal Antibodies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Vaccines Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Cell Therapies and Biological Therapies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Gene Therapies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Fill Finish Manufacturing Market Share (%) – End User, 2022 and 2030
Figure 16. Contract Manufacturing Organizations Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. Biopharmaceutical Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Middle East & Africa Fill Finish Manufacturing Market, by Key Countries – Revenue (2022) (US$ Million)
Figure 20. Middle East & Africa Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 21. South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 22. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 23. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 24. Rest of Middle East & Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 25. Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023

The List of Companies – Middle East & Africa Fill Finish Manufacturing Market

1. Becton Dickinson and Co
2. IMA Industria Macchine Automatiche SpA
3. Maquinaria Industrial Dara SL
4. Nipro Medical Europe NV
5. Schott AG
6. SGD SA
7. Syntegon Technology GmbH
8. West Pharmaceutical Services Inc

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Fill Finish Manufacturing Market Forecast to 2030”